PT  - JOURNAL ARTICLE
AU  - Salichos, Leonidas
AU  - Warrell, Jonathan
AU  - Cevasco, Hannah
AU  - Chung, Alvin
AU  - Gerstein, Mark
TI  - Genetic determination of regional connectivity in modelling the spread of COVID-19 outbreak for improved mitigation strategies
AID  - 10.1101/2021.01.30.21250785
DP  - 2021 Jan 01
TA  - medRxiv
PG  - 2021.01.30.21250785
4099  - http://medrxiv.org/content/early/2021/02/02/2021.01.30.21250785.short
4100  - http://medrxiv.org/content/early/2021/02/02/2021.01.30.21250785.full
AB  - Covid-19 has resulted in the death of more than 1,500,000 individuals. Due to the pandemic’s severity, thousands of genomes have been sequenced and publicly stored with extensive records, an unprecedented amount of data for an outbreak in a single year. Simultaneously, prediction models offered region-specific and often contradicting results, while states or countries implemented mitigation strategies with little information on success, precision, or agreement with neighboring regions. Even though viral transmissions have been already documented in a historical and geographical context, few studies aimed to model geographic and temporal flow from viral sequence information. Here, using a case study of 7 states, we model the flow of the Covid-19 outbreak with respect to phylogenetic information, viral migration, inter- and intra- regional connectivity, epidemiologic and demographic characteristics. By assessing regional connectivity from genomic variants, we can significantly improve predictions in modeling the viral spread and intensity.Contrary to previous results, our study shows that the vast majority of the first outbreak can be traced to very few lineages, despite the existence of multiple worldwide transmissions. Moreover, our results show that while the distance from hotspots is initially important, connectivity becomes increasingly significant as the virus establishes itself. Similarly, isolated local strategies-such as relying on herd immunity-can negatively impact neighboring states. Our work suggests that we can achieve more efficient unified mitigation strategies with selective interventions.Competing Interest StatementThe authors have declared no competing interest.Clinical TrialPublic data implementationFunding StatementN/AAuthor DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:N/AAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAll data are available in public databases.